(800) 526-OPYS Pay my bill Member login
logo
  • Hospital Solutions
    • Emergency Medicine
    • Hospital Medicine
    • Post Acute Care
    • Urgent Care
    • Telemedicine
  • Join our Team
    • Physicians
    • Advanced Practitioners
    • Career Opportunities
  • About OPYS
    • Experienced Group
    • Metrics & Outcomes
    • Throughout the US
    • Quality Patient Care
    • Clinical Performance
    • Qualified Providers
    • Company Profile
    • Leadership Team
    • Mission Statement
    • Reviews
  • News
  • Contact Us

New Data on the Relationship Between Antidepressants and Type 2 Diabetes

Home > Patient Care > New Data on the Relationship Between Antidepressants and Type 2 Diabetes

New Data on the Relationship Between Antidepressants and Type 2 Diabetes

September 10, 2020

There has been mixed data on whether the use of antidepressants may increase people’s risk for developing type 2 diabetes. Whereas some meta-analyses have pointed to a potential relationship, longitudinal studies have not identified any correlation.

To investigate this issue, researchers have now analyzed relevant  data from a French cohort study that began in 1990 and included follow up questionnaires every two or three years. Information on type 2 diabetes status and exposure to antidepressants was obtained through drug reimbursement data.

The researchers found that of the 63,999 women who were initially not taking any medications for type 2 diabetes, 1,124 developed type 2 diabetes over the 6 subsequent years that their information was tracked. Compared to those who did not use antidepressants, those taking antidepressants were more likely to develop type 2 diabetes.

An analysis of how the type of antidepressant may modify type 2 diabetes risk was also undertaken. The results showed that while women taking selective serotonin reuptake inhibitors (SSRIs) had a 1.25 fold increased risk for type 2 diabetes, those taking imipramine-type and ‘other’ or ‘mixed’ antidepressants had 1.35 fold and 1.82 fold increased risk.

Based on their results, the authors of the study suggest that glucose levels be monitored in those who are put on antidepressants. More research will likely help to clarify if and how antidepressants may affect glucose metabolism and risk for type 2 diabetes and how that risk can be effectively managed by physicians so that those who need antidepressant medication can get the treatment they need as safely as possible.

 

 

Reference

 

Da Silva, M.A. et al. (2020). Increased risk of type 2 diabetes in antidepressant users: evidence from a 6-year longitudinal study in the E3N cohort. https://doi.org/10.1111/dme.14345

 

 

Filed Under: Best Practice, General, Patient Care, Public Health Tagged With: Diabetes, Health care, Hospital Physicians, Medications, patient care

Search

Categories

  • Best Practice
  • Cardiologists
  • COVID-19
  • Emergency Physicians
  • General
  • Health Technology
  • Hospital Physicians
  • Hospitalists
  • New Job Opportunities
  • Patient Care
  • Physician Job
  • Physician Services News
  • Public Health
  • Reimbursement
  • Women's Health

Archives

  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • December 2017
  • March 2017
  • June 2016
  • August 2015
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

We’d Love to Hear From You,
Get In Touch With Us!

logo

Quality, efficient, patient-centered healthcare through experienced medical leadership, communication, and collaboration in the provision of hospital-based physician outsourcing services.

Our Services
  • Emergency Medicine
  • Hospital Medicine
  • Post Acute Care
  • Urgent Care
  • Telemedicine
OPYS Advantage
  • Our Team
  • Investor Relations
  • Career Opportunities
Contact
Corporate Office 

One Indiana Square, Suite 2060
Indianapolis, IN 46204

Southern Region 

7119 Afton Drive, Suite 101A
Knoxville, TN 37918

Phone: (800) 526-6797
Fax: (800) 456-6148
Email: info@opys.com

Copyright © 2021. All rights reserved I Site Map I Privacy Policy I Terms and Use

Digital Marketing by